Previous 10 | Next 10 |
ClearPoint Neuro's (NASDAQ:CLPT) stock rose ~18% after the company's Q1 results beat analysts' estimates and it raised lower-end of its FY22 revenue outlook a day ago. Net loss narrowed to -$3.96M, compared to -$2.54M in Q1 2021. GAAP EPS of -$0.17, beat estimates by $0.03. Total revenue...
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Conference Call May 11, 2022 16:30 ET Company Participants Joe Burnett - President & Chief Executive Officer Danilo D’Alessandro - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Marc W...
Image source: The Motley Fool. ClearPoint Neuro, Inc. (NASDAQ: CLPT) Q1 2022 Earnings Call May 11, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript
ClearPoint Neuro press release (NASDAQ:CLPT): Q1 GAAP EPS of -$0.17 beats by $0.03. Revenue of $5.03M (+24.8% Y/Y) beats by $0.85M. For further details see: ClearPoint Neuro GAAP EPS of -$0.17 beats by $0.03, revenue of $5.03M beats by $0.85M
SOLANA BEACH, Calif., May 11, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its first quarter ended March 31,...
ClearPoint Neuro (NASDAQ:CLPT) Q1 consensus EPS estimate is -$0.20 and consensus revenue estimate is $4.18M (+3.7% Y/Y). CLPT is scheduled to announce Q1 earnings results on Wednesday, May 11, after market close. For further details see: ClearPoint Neuro Q1 2022 Earnings ...
ACOR, ADMA, APP, ASM, ASND, ASYS, ATCO, BAK, BMBL, BROS, BYND, CLPT, CLSD, CPA, CPNG, CYCC, DIS, DOX, ENVX, FLNC, FOSL, FSM, GAIN, GBDC, ICAD, KGC, LGO, LKCO, LTBR, MBII, METC, MFC, MQ, MRAM, MYO, NEON, NOAH, OCX, ONTX, OR, OTRK, PAAS, PAYS, PSTL, OTCPK:PWCDF, RIVN, SAND, SCM, SCTL, SLF, SMTS...
SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a collaboration with Higgs Boson Health (Durham, NC) to brin...
SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its ...
ClearPoint Neuro (NASDAQ:CLPT) on Wednesday said it expanded its worldwide license and research deal with Philips to include access to technology to enable surgical navigation using computed tomography (CT). ClearPoint Maestro Brain Model for the Operating Room aims to enable highly accurate ...
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
ClearPoint Neuro, Inc. Website:
SOLANA BEACH, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its ...
2024-07-15 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...